Oxymatrine mitigates Aspergillus fumigatus keratitis by suppressing fungal activity and restricting pyroptosis

Fungal keratitis (FK) is a refractory keratitis caused by excessive inflammation and fungal damage. Excessive inflammation can lead to tissue damage and corneal opacity, resulting in a poor prognosis for FK. Oxymatrine (OMT) is a natural alkaloid, which has rich pharmacological effects, such as anti...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Experimental eye research 2024-03, Vol.240, p.109830-109830, Article 109830
Hauptverfasser: Liu, Weichen, Tian, Xue, Gu, Lingwen, Yu, Bing, Wang, Ziyi, Chi, Menghui, Lin, Jing, Wang, Qian, Liu, Guibo, Zhao, Guiqiu, Cui Li
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 109830
container_issue
container_start_page 109830
container_title Experimental eye research
container_volume 240
creator Liu, Weichen
Tian, Xue
Gu, Lingwen
Yu, Bing
Wang, Ziyi
Chi, Menghui
Lin, Jing
Wang, Qian
Liu, Guibo
Zhao, Guiqiu
Cui Li
description Fungal keratitis (FK) is a refractory keratitis caused by excessive inflammation and fungal damage. Excessive inflammation can lead to tissue damage and corneal opacity, resulting in a poor prognosis for FK. Oxymatrine (OMT) is a natural alkaloid, which has rich pharmacological effects, such as antioxidant and anti-inflammation. However, its antifungal activity and the mechanism of action in FK have not been elucidated. This study confirmed that OMT suppressed Aspergillus fumigatus growth, biofilm formation, the integrity of fungal cell and conidial adherence. OMT not only effectively reduced corneal fungal load but also inflammation responses. OMT lessened the recruitment of neutrophils and macrophages in FK. In addition, OMT up-regulated the expression of Nrf2 and down-regulated the expression of IL-18, IL-1β, caspase-1, NLRP3 and GSDMD. Pre-treatment with Nrf2 inhibitor up-regulated the expression of IL-1β, IL-18, caspase-1, NLRP3 and GSDMD supressed by OMT. In conclusion, OMT has efficient anti-inflammatory and antifungal effects by suppressing fungal activity and restricting pyroptosis via Nrf2 pathway. OMT is considered as a potential option for the treatment of FK. •Oxymatrine alleviated the severity of mouse fungal keratitis.•Oxymatrine exerted antifungal effects to suppress A. fumigatus growth.•Oxymatrine lessened infiltration of neutrophils and macrophages in mouse fungal keratitis.•Oxymatrine suppressed the excessive inflammatory response by inhibiting pyroptosis via Nrf2 pathway during fungal infections.
doi_str_mv 10.1016/j.exer.2024.109830
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2928246010</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0014483524000514</els_id><sourcerecordid>2928246010</sourcerecordid><originalsourceid>FETCH-LOGICAL-c307t-f7f4e44516fbb2006668b443c5cfd3773d720c08d494b6eeaafb0d7101773d9c3</originalsourceid><addsrcrecordid>eNp9kE9v1DAQxS1ERZfCF-CAcuSSZWJ7nUTiUlVtQarUC5wtx5msvOQfHqdqvn0n2sKRk0fvvXka_4T4VMC-gMJ8Pe3xGeNegtQs1JWCN2LHg8kBoHwrdgCFznWlDpfiPdGJVaVL_U5cqkoZXSu5E-Pj8zq4FMOI2RBSOLqElF3TjPEY-n6hrFuGTeXpN0aXOENZs2a0zHNEojAeOTIeXZ85n8JTSGvmxjZjj1tZYX9e4zSniQJ9EBed6wk_vr5X4tfd7c-b7_nD4_2Pm-uH3CsoU96VnUatD4XpmkYCGGOqRmvlD75rVVmqtpTgoWp1rRuD6FzXQFsylc2rvboSX869c5z-LHyKHQJ57Hs34rSQlbWspDZQAEflOerjRBSxs3MMg4urLcBunO3JbpztxtmeOfPS59f-pRmw_bfyFywHvp0DyL98CrxOPuDosQ0RfbLtFP7X_wKEapH4</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2928246010</pqid></control><display><type>article</type><title>Oxymatrine mitigates Aspergillus fumigatus keratitis by suppressing fungal activity and restricting pyroptosis</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Liu, Weichen ; Tian, Xue ; Gu, Lingwen ; Yu, Bing ; Wang, Ziyi ; Chi, Menghui ; Lin, Jing ; Wang, Qian ; Liu, Guibo ; Zhao, Guiqiu ; Cui Li</creator><creatorcontrib>Liu, Weichen ; Tian, Xue ; Gu, Lingwen ; Yu, Bing ; Wang, Ziyi ; Chi, Menghui ; Lin, Jing ; Wang, Qian ; Liu, Guibo ; Zhao, Guiqiu ; Cui Li</creatorcontrib><description>Fungal keratitis (FK) is a refractory keratitis caused by excessive inflammation and fungal damage. Excessive inflammation can lead to tissue damage and corneal opacity, resulting in a poor prognosis for FK. Oxymatrine (OMT) is a natural alkaloid, which has rich pharmacological effects, such as antioxidant and anti-inflammation. However, its antifungal activity and the mechanism of action in FK have not been elucidated. This study confirmed that OMT suppressed Aspergillus fumigatus growth, biofilm formation, the integrity of fungal cell and conidial adherence. OMT not only effectively reduced corneal fungal load but also inflammation responses. OMT lessened the recruitment of neutrophils and macrophages in FK. In addition, OMT up-regulated the expression of Nrf2 and down-regulated the expression of IL-18, IL-1β, caspase-1, NLRP3 and GSDMD. Pre-treatment with Nrf2 inhibitor up-regulated the expression of IL-1β, IL-18, caspase-1, NLRP3 and GSDMD supressed by OMT. In conclusion, OMT has efficient anti-inflammatory and antifungal effects by suppressing fungal activity and restricting pyroptosis via Nrf2 pathway. OMT is considered as a potential option for the treatment of FK. •Oxymatrine alleviated the severity of mouse fungal keratitis.•Oxymatrine exerted antifungal effects to suppress A. fumigatus growth.•Oxymatrine lessened infiltration of neutrophils and macrophages in mouse fungal keratitis.•Oxymatrine suppressed the excessive inflammatory response by inhibiting pyroptosis via Nrf2 pathway during fungal infections.</description><identifier>ISSN: 0014-4835</identifier><identifier>EISSN: 1096-0007</identifier><identifier>DOI: 10.1016/j.exer.2024.109830</identifier><identifier>PMID: 38364932</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Animals ; Antifungal Agents - pharmacology ; Antifungal Agents - therapeutic use ; Aspergillosis - drug therapy ; Aspergillosis - metabolism ; Aspergillus fumigatus - physiology ; Aspergillus fumigatus keratitis ; Caspase 1 - metabolism ; Corneal Ulcer ; Eye Infections, Fungal - drug therapy ; Eye Infections, Fungal - metabolism ; Inflammation ; Interleukin-18 ; Keratitis - microbiology ; Matrines ; Mice ; Mice, Inbred C57BL ; NF-E2-Related Factor 2 ; NLR Family, Pyrin Domain-Containing 3 Protein ; NLRP3 ; Oxymatrine ; Pyroptosis</subject><ispartof>Experimental eye research, 2024-03, Vol.240, p.109830-109830, Article 109830</ispartof><rights>2024 Elsevier Ltd</rights><rights>Copyright © 2024 Elsevier Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c307t-f7f4e44516fbb2006668b443c5cfd3773d720c08d494b6eeaafb0d7101773d9c3</cites><orcidid>0000-0003-4643-072X</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0014483524000514$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38364932$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Liu, Weichen</creatorcontrib><creatorcontrib>Tian, Xue</creatorcontrib><creatorcontrib>Gu, Lingwen</creatorcontrib><creatorcontrib>Yu, Bing</creatorcontrib><creatorcontrib>Wang, Ziyi</creatorcontrib><creatorcontrib>Chi, Menghui</creatorcontrib><creatorcontrib>Lin, Jing</creatorcontrib><creatorcontrib>Wang, Qian</creatorcontrib><creatorcontrib>Liu, Guibo</creatorcontrib><creatorcontrib>Zhao, Guiqiu</creatorcontrib><creatorcontrib>Cui Li</creatorcontrib><title>Oxymatrine mitigates Aspergillus fumigatus keratitis by suppressing fungal activity and restricting pyroptosis</title><title>Experimental eye research</title><addtitle>Exp Eye Res</addtitle><description>Fungal keratitis (FK) is a refractory keratitis caused by excessive inflammation and fungal damage. Excessive inflammation can lead to tissue damage and corneal opacity, resulting in a poor prognosis for FK. Oxymatrine (OMT) is a natural alkaloid, which has rich pharmacological effects, such as antioxidant and anti-inflammation. However, its antifungal activity and the mechanism of action in FK have not been elucidated. This study confirmed that OMT suppressed Aspergillus fumigatus growth, biofilm formation, the integrity of fungal cell and conidial adherence. OMT not only effectively reduced corneal fungal load but also inflammation responses. OMT lessened the recruitment of neutrophils and macrophages in FK. In addition, OMT up-regulated the expression of Nrf2 and down-regulated the expression of IL-18, IL-1β, caspase-1, NLRP3 and GSDMD. Pre-treatment with Nrf2 inhibitor up-regulated the expression of IL-1β, IL-18, caspase-1, NLRP3 and GSDMD supressed by OMT. In conclusion, OMT has efficient anti-inflammatory and antifungal effects by suppressing fungal activity and restricting pyroptosis via Nrf2 pathway. OMT is considered as a potential option for the treatment of FK. •Oxymatrine alleviated the severity of mouse fungal keratitis.•Oxymatrine exerted antifungal effects to suppress A. fumigatus growth.•Oxymatrine lessened infiltration of neutrophils and macrophages in mouse fungal keratitis.•Oxymatrine suppressed the excessive inflammatory response by inhibiting pyroptosis via Nrf2 pathway during fungal infections.</description><subject>Animals</subject><subject>Antifungal Agents - pharmacology</subject><subject>Antifungal Agents - therapeutic use</subject><subject>Aspergillosis - drug therapy</subject><subject>Aspergillosis - metabolism</subject><subject>Aspergillus fumigatus - physiology</subject><subject>Aspergillus fumigatus keratitis</subject><subject>Caspase 1 - metabolism</subject><subject>Corneal Ulcer</subject><subject>Eye Infections, Fungal - drug therapy</subject><subject>Eye Infections, Fungal - metabolism</subject><subject>Inflammation</subject><subject>Interleukin-18</subject><subject>Keratitis - microbiology</subject><subject>Matrines</subject><subject>Mice</subject><subject>Mice, Inbred C57BL</subject><subject>NF-E2-Related Factor 2</subject><subject>NLR Family, Pyrin Domain-Containing 3 Protein</subject><subject>NLRP3</subject><subject>Oxymatrine</subject><subject>Pyroptosis</subject><issn>0014-4835</issn><issn>1096-0007</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kE9v1DAQxS1ERZfCF-CAcuSSZWJ7nUTiUlVtQarUC5wtx5msvOQfHqdqvn0n2sKRk0fvvXka_4T4VMC-gMJ8Pe3xGeNegtQs1JWCN2LHg8kBoHwrdgCFznWlDpfiPdGJVaVL_U5cqkoZXSu5E-Pj8zq4FMOI2RBSOLqElF3TjPEY-n6hrFuGTeXpN0aXOENZs2a0zHNEojAeOTIeXZ85n8JTSGvmxjZjj1tZYX9e4zSniQJ9EBed6wk_vr5X4tfd7c-b7_nD4_2Pm-uH3CsoU96VnUatD4XpmkYCGGOqRmvlD75rVVmqtpTgoWp1rRuD6FzXQFsylc2rvboSX869c5z-LHyKHQJ57Hs34rSQlbWspDZQAEflOerjRBSxs3MMg4urLcBunO3JbpztxtmeOfPS59f-pRmw_bfyFywHvp0DyL98CrxOPuDosQ0RfbLtFP7X_wKEapH4</recordid><startdate>202403</startdate><enddate>202403</enddate><creator>Liu, Weichen</creator><creator>Tian, Xue</creator><creator>Gu, Lingwen</creator><creator>Yu, Bing</creator><creator>Wang, Ziyi</creator><creator>Chi, Menghui</creator><creator>Lin, Jing</creator><creator>Wang, Qian</creator><creator>Liu, Guibo</creator><creator>Zhao, Guiqiu</creator><creator>Cui Li</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-4643-072X</orcidid></search><sort><creationdate>202403</creationdate><title>Oxymatrine mitigates Aspergillus fumigatus keratitis by suppressing fungal activity and restricting pyroptosis</title><author>Liu, Weichen ; Tian, Xue ; Gu, Lingwen ; Yu, Bing ; Wang, Ziyi ; Chi, Menghui ; Lin, Jing ; Wang, Qian ; Liu, Guibo ; Zhao, Guiqiu ; Cui Li</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c307t-f7f4e44516fbb2006668b443c5cfd3773d720c08d494b6eeaafb0d7101773d9c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Animals</topic><topic>Antifungal Agents - pharmacology</topic><topic>Antifungal Agents - therapeutic use</topic><topic>Aspergillosis - drug therapy</topic><topic>Aspergillosis - metabolism</topic><topic>Aspergillus fumigatus - physiology</topic><topic>Aspergillus fumigatus keratitis</topic><topic>Caspase 1 - metabolism</topic><topic>Corneal Ulcer</topic><topic>Eye Infections, Fungal - drug therapy</topic><topic>Eye Infections, Fungal - metabolism</topic><topic>Inflammation</topic><topic>Interleukin-18</topic><topic>Keratitis - microbiology</topic><topic>Matrines</topic><topic>Mice</topic><topic>Mice, Inbred C57BL</topic><topic>NF-E2-Related Factor 2</topic><topic>NLR Family, Pyrin Domain-Containing 3 Protein</topic><topic>NLRP3</topic><topic>Oxymatrine</topic><topic>Pyroptosis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Liu, Weichen</creatorcontrib><creatorcontrib>Tian, Xue</creatorcontrib><creatorcontrib>Gu, Lingwen</creatorcontrib><creatorcontrib>Yu, Bing</creatorcontrib><creatorcontrib>Wang, Ziyi</creatorcontrib><creatorcontrib>Chi, Menghui</creatorcontrib><creatorcontrib>Lin, Jing</creatorcontrib><creatorcontrib>Wang, Qian</creatorcontrib><creatorcontrib>Liu, Guibo</creatorcontrib><creatorcontrib>Zhao, Guiqiu</creatorcontrib><creatorcontrib>Cui Li</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Experimental eye research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Liu, Weichen</au><au>Tian, Xue</au><au>Gu, Lingwen</au><au>Yu, Bing</au><au>Wang, Ziyi</au><au>Chi, Menghui</au><au>Lin, Jing</au><au>Wang, Qian</au><au>Liu, Guibo</au><au>Zhao, Guiqiu</au><au>Cui Li</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Oxymatrine mitigates Aspergillus fumigatus keratitis by suppressing fungal activity and restricting pyroptosis</atitle><jtitle>Experimental eye research</jtitle><addtitle>Exp Eye Res</addtitle><date>2024-03</date><risdate>2024</risdate><volume>240</volume><spage>109830</spage><epage>109830</epage><pages>109830-109830</pages><artnum>109830</artnum><issn>0014-4835</issn><eissn>1096-0007</eissn><abstract>Fungal keratitis (FK) is a refractory keratitis caused by excessive inflammation and fungal damage. Excessive inflammation can lead to tissue damage and corneal opacity, resulting in a poor prognosis for FK. Oxymatrine (OMT) is a natural alkaloid, which has rich pharmacological effects, such as antioxidant and anti-inflammation. However, its antifungal activity and the mechanism of action in FK have not been elucidated. This study confirmed that OMT suppressed Aspergillus fumigatus growth, biofilm formation, the integrity of fungal cell and conidial adherence. OMT not only effectively reduced corneal fungal load but also inflammation responses. OMT lessened the recruitment of neutrophils and macrophages in FK. In addition, OMT up-regulated the expression of Nrf2 and down-regulated the expression of IL-18, IL-1β, caspase-1, NLRP3 and GSDMD. Pre-treatment with Nrf2 inhibitor up-regulated the expression of IL-1β, IL-18, caspase-1, NLRP3 and GSDMD supressed by OMT. In conclusion, OMT has efficient anti-inflammatory and antifungal effects by suppressing fungal activity and restricting pyroptosis via Nrf2 pathway. OMT is considered as a potential option for the treatment of FK. •Oxymatrine alleviated the severity of mouse fungal keratitis.•Oxymatrine exerted antifungal effects to suppress A. fumigatus growth.•Oxymatrine lessened infiltration of neutrophils and macrophages in mouse fungal keratitis.•Oxymatrine suppressed the excessive inflammatory response by inhibiting pyroptosis via Nrf2 pathway during fungal infections.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>38364932</pmid><doi>10.1016/j.exer.2024.109830</doi><tpages>1</tpages><orcidid>https://orcid.org/0000-0003-4643-072X</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0014-4835
ispartof Experimental eye research, 2024-03, Vol.240, p.109830-109830, Article 109830
issn 0014-4835
1096-0007
language eng
recordid cdi_proquest_miscellaneous_2928246010
source MEDLINE; Elsevier ScienceDirect Journals
subjects Animals
Antifungal Agents - pharmacology
Antifungal Agents - therapeutic use
Aspergillosis - drug therapy
Aspergillosis - metabolism
Aspergillus fumigatus - physiology
Aspergillus fumigatus keratitis
Caspase 1 - metabolism
Corneal Ulcer
Eye Infections, Fungal - drug therapy
Eye Infections, Fungal - metabolism
Inflammation
Interleukin-18
Keratitis - microbiology
Matrines
Mice
Mice, Inbred C57BL
NF-E2-Related Factor 2
NLR Family, Pyrin Domain-Containing 3 Protein
NLRP3
Oxymatrine
Pyroptosis
title Oxymatrine mitigates Aspergillus fumigatus keratitis by suppressing fungal activity and restricting pyroptosis
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-06T08%3A26%3A14IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Oxymatrine%20mitigates%20Aspergillus%20fumigatus%20keratitis%20by%20suppressing%20fungal%20activity%20and%20restricting%20pyroptosis&rft.jtitle=Experimental%20eye%20research&rft.au=Liu,%20Weichen&rft.date=2024-03&rft.volume=240&rft.spage=109830&rft.epage=109830&rft.pages=109830-109830&rft.artnum=109830&rft.issn=0014-4835&rft.eissn=1096-0007&rft_id=info:doi/10.1016/j.exer.2024.109830&rft_dat=%3Cproquest_cross%3E2928246010%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2928246010&rft_id=info:pmid/38364932&rft_els_id=S0014483524000514&rfr_iscdi=true